PracticeVideosBlogFlashcardsEspañol
All Practice Exams

100+ Free Czech Gynaecology and Obstetrics Board Exam Practice Questions

Prepare for the Atestační zkouška v oboru Gynekologie a porodnictví exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
100+ Questions
100% Free

Loading practice questions...

Same family resources

Explore More Czech Medical Specialty Board Examinations (Atestační zkoušky — MZ ČR / IPVZ)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Czech Specialty Examination in Anaesthesiology and Intensive Care (Atestace — Anesteziologie a intenzivní medicína)

Practice Questions

Czech Specialty Examination in Dermatology and Venereology (Atestace — Dermatovenerologie)

Practice Questions

Czech Specialty Examination in General Practice (Atestace — Všeobecné praktické lékařství)

Practice Questions

Czech Specialty Examination in Internal Medicine (Atestace — Vnitřní lékařství)

Practice Questions

Czech Specialty Examination in Neurology (Atestace — Neurologie)

Practice Questions

Czech Specialty Examination in Ophthalmology (Atestace — Oftalmologie)

Practice Questions
2026 Statistics

Key Facts: Czech Gynaecology and Obstetrics Board Exam Exam

5 years

Minimum postgraduate specialty training

Věstník MZ ČR educational curriculum

2 parts

Practical clinical & oral theoretical board

Vyhláška č. 282/2019 Sb. § 45

≥3 members

Examination board committee size

Zákon č. 95/2004 Sb. § 21

CZK 500

Standard statutory examination fee

Nařízení vlády č. 324/2018 Sb.

Max 2

Permitted retake attempts

Zákon č. 95/2004 Sb. § 21

The Czech Gynaecology and Obstetrics Specialty Board Exam (Atestace) is the statutory post-residency certification administered by MZ ČR, accredited medical faculties, and IPVZ under Act No. 95/2004 Sb. and Decree No. 282/2019 Sb. It features a practical clinical evaluation and an oral theoretical board exam before a 3-member committee. Fees are CZK 500 for the first sitting under NV No. 324/2018 Sb. This 100-question English bank adapts the core curriculum into verified clinical scenarios.

Sample Czech Gynaecology and Obstetrics Board Exam Practice Questions

Try these sample questions to test your Czech Gynaecology and Obstetrics Board Exam exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 29-year-old primigravida presents for first-trimester combined aneuploidy screening. At what gestational age window based on crown-rump length (CRL) should the ultrasound measurement of fetal nuchal translucency (NT) be performed according to FMF and Czech (ČGPS) guidelines?
A.11 weeks 0 days to 13 weeks 6 days (CRL 45 to 84 mm)
B.9 weeks 0 days to 11 weeks 6 days (CRL 25 to 44 mm)
C.14 weeks 0 days to 16 weeks 6 days (CRL 85 to 110 mm)
D.16 weeks 0 days to 18 weeks 6 days (CRL 115 to 140 mm)
Explanation: First-trimester combined screening integrates maternal serum markers (free beta-hCG and PAPP-A) with ultrasound measurement of fetal nuchal translucency. Validated Fetal Medicine Foundation (FMF) and ČGPS standards strictly require a crown-rump length between 45 mm and 84 mm, corresponding to 11+0 to 13+6 weeks of gestation. Outside this embryonic developmental window, normal fluid dynamics alter NT thickness and invalidate standard risk calculation algorithms.
2According to ČGPS and international consensus guidelines (ISSNP/FIGO), which finding definitively confirms the diagnosis of preeclampsia in a previously normotensive woman at 28 weeks of gestation with blood pressure 150/95 mmHg?
A.New-onset significant proteinuria of >= 300 mg/24 hours or protein/creatinine ratio >= 30 mg/mmol
B.Isolated asymptomatic trace glucosuria on dipstick testing with normal renal markers
C.Mild pedal pitting edema resolving with leg elevation and left lateral recumbency
D.A physiological drop in serum creatinine from 70 umol/L to 50 umol/L
Explanation: Preeclampsia is defined as new-onset hypertension (systolic BP >= 140 mmHg and/or diastolic BP >= 90 mmHg on two occasions) occurring after 20 weeks of gestation accompanied by significant proteinuria (>= 300 mg/24 h or urine protein/creatinine ratio >= 30 mg/mmol) or maternal organ dysfunction. Maternal end-organ dysfunction may include renal insufficiency, hepatic impairment, thrombocytopenia, neurological symptoms, or uteroplacental dysfunction. Neither isolated glucosuria nor dependent edema fulfills modern diagnostic criteria.
3A 32-year-old multigravida with a history of early-onset preeclampsia in her previous pregnancy attends her booking visit at 10 weeks. What pharmacologic prophylaxis is recommended by Czech (ČGPS) and European guidelines to reduce her recurrence risk?
A.Low-dose acetylsalicylic acid (100–150 mg daily) initiated before 16 weeks of gestation
B.Continuous unfractionated heparin infusion initiated immediately upon positive pregnancy test
C.Prophylactic high-dose oral prednisone therapy throughout the entire second trimester
D.High-dose loop diuretics (furosemide 40 mg daily) to prevent volume expansion
Explanation: Low-dose aspirin (100 to 150 mg orally once daily, preferably taken at bedtime) initiated between 12 and 16 weeks of gestation significantly reduces the risk of preterm preeclampsia and fetal growth restriction in high-risk women. Aspirin selectively inhibits thromboxane A2 production without suppressing prostacyclin, promoting healthy trophoblastic spiral artery remodelling. Therapy is typically maintained until 36 weeks of gestation.
4A 34-week pregnant woman with severe preeclampsia exhibits hyperreflexia, persistent clonus, and visual scotomata. Which drug regimen is the first-line standard of care to prevent eclamptic seizures?
A.Intravenous magnesium sulfate: 4–6 g loading dose over 15–20 minutes, followed by 1–2 g/h continuous infusion
B.Intravenous diazepam: 10 mg bolus repeated every 15 minutes up to a maximum of 100 mg
C.Intravenous phenytoin: 18 mg/kg loading dose administered over 60 minutes under ECG monitoring
D.Sublingual nifedipine: 20 mg bite-and-swallow capsule administered every 30 minutes
Explanation: Magnesium sulfate is the undisputed gold-standard neuroprotective agent for the prevention and treatment of eclamptic convulsions (supported by the Magpie Trial and ČGPS guidelines). It acts as a central NMDA receptor antagonist and promotes cerebral vasodilation, outperforming phenytoin and benzodiazepines in seizure prevention and maternal mortality reduction. Monitoring requires assessment of patellar reflexes, respiratory rate (>= 12/min), and hourly urine output (>= 30 mL/h) to avoid magnesium toxicity.
5A 31-year-old woman at 33 weeks of gestation presents with severe right upper quadrant epigastric pain, nausea, and vomiting. Laboratory tests reveal microangiopathic hemolytic anemia with schistocytes, AST 380 U/L, ALT 410 U/L, and platelet count 68 x 10^9/L. What is the definitive management of this condition?
A.Prompt maternal stabilization (antihypertensives, magnesium sulfate) followed by delivery of the fetus
B.Expectant outpatient management with oral ursodeoxycholic acid and weekly liver function tests
C.High-dose plasmapheresis while continuing the pregnancy until at least 37 completed weeks
D.Immediate urgent exploratory laparotomy for suspected acute calculous cholecystitis
Explanation: This patient meets full criteria for HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets), a severe variant of preeclampsia characterised by systemic microvascular endothelial injury and hepatic sinusoid fibrin deposition. The definitive treatment for HELLP syndrome is delivery, regardless of gestational age, once maternal stabilization (blood pressure control and magnesium sulfate seizure prophylaxis) is achieved. Conservative prolongation of pregnancy beyond 24–48 hours carries high risks of hepatic rupture, placental abruption, DIC, and maternal death.
6In the Czech Republic, universal screening for gestational diabetes mellitus (GDM) is performed at 24 to 28 weeks of gestation using a standard 75 g oral glucose tolerance test (oGTT). According to ČGPS/ČDS guidelines, which set of venous plasma glucose cut-offs (fasting, 1-hour, 2-hour) establishes the diagnosis if at least one value is met or exceeded?
A.Fasting >= 5.1 mmol/L, 1-hour >= 10.0 mmol/L, 2-hour >= 8.5 mmol/L
B.Fasting >= 5.6 mmol/L, 1-hour >= 11.1 mmol/L, 2-hour >= 10.0 mmol/L
C.Fasting >= 6.1 mmol/L, 1-hour >= 8.0 mmol/L, 2-hour >= 7.8 mmol/L
D.Fasting >= 7.0 mmol/L, 1-hour >= 12.5 mmol/L, 2-hour >= 11.1 mmol/L
Explanation: Czech national guidelines (ČGPS ČLS JEP and Česká diabetologická společnost) follow the IADPSG criteria: GDM is diagnosed during the 24–28 week 75 g oGTT if any single venous plasma value is reached or exceeded: fasting >= 5.1 mmol/L, 1-hour >= 10.0 mmol/L, or 2-hour >= 8.5 mmol/L. In early pregnancy (up to 14 weeks), fasting plasma glucose is screened separately; a confirmed fasting level >= 5.1 mmol/L in early pregnancy also indicates GDM.
7A 28-year-old woman with gestational diabetes mellitus at 29 weeks has failed to achieve target glycaemic levels (fasting < 5.3 mmol/L, 1-hour postprandial < 7.8 mmol/L) despite 2 weeks of strict dietary modification and exercise. What is the first-line pharmacologic therapy in Czech and European obstetric practice?
A.Human insulin or approved insulin analogues (e.g., insulin aspart, lispro, detemir)
B.Oral sulfonylurea therapy with high-dose glibenclamide
C.Glucagon-like peptide-1 (GLP-1) receptor agonists (e.g., semaglutide)
D.Sodium-glucose co-transporter 2 (SGLT-2) inhibitors (e.g., empagliflozin)
Explanation: Insulin is the undisputed first-line pharmacologic therapy for gestational diabetes mellitus in Czech and European guidelines when medical nutrition therapy fails to maintain normoglycemia. Insulin does not cross the placental barrier in significant amounts, effectively controls maternal blood glucose, and has no teratogenic or embryotoxic effects. While metformin may be considered in selected scenarios, GLP-1 agonists and SGLT2 inhibitors are strictly contraindicated in pregnancy.
8On third-trimester Doppler ultrasound in a fetus with suspected fetal growth restriction (FGR) at 30 weeks, the umbilical artery shows persistent absent end-diastolic velocity (AEDV). What underlying hemodynamic abnormality does this finding reflect?
A.Severe downstream placental vascular resistance obliterating more than 60–70% of tertiary placental villous vascular channels
B.Congenital fetal tricuspid regurgitation resulting in right ventricular volume overload
C.Severe fetal intracranial arterial vasospasm secondary to cytomegalovirus ventriculitis
D.Acute maternal renal artery stenosis with systemic reflex hypotension
Explanation: Absent end-diastolic velocity (AEDV) in the umbilical artery reflects critically elevated resistance in the placental capillary bed, corresponding histologically to the obliteration, sclerosis, or failure of development of over 60–70% of tertiary stem villi. This placental vascular insufficiency causes fetal hypoxemia and acidemia, triggering compensatory mechanisms such as the brain-sparing effect (decreased middle cerebral artery pulsatility index). Continued deterioration leads to reversed end-diastolic velocity (REDV), indicating impending fetal demise.
9In a growth-restricted fetus at 29 weeks of gestation undergoing serial surveillance according to TRUFFLE and ISUOG criteria, which Doppler finding has the strongest association with impending fetal stillbirth and constitutes an indication for delivery (after completing antenatal steroids)?
A.Persistent absent or reversed flow during atrial contraction (a-wave) in the ductus venosus
B.Elevated pulsatility index in the umbilical artery with preserved positive forward diastolic flow
C.Reduced middle cerebral artery pulsatility index (MCA-PI < 5th centile) with normal venous flow
D.Slight unilateral notch in the maternal uterine artery Doppler waveforms
Explanation: Absent or reversed flow during the atrial contraction (reversed a-wave) in the ductus venosus is a late and ominous hemodynamic sign of advanced fetal myocardial acidemia and right heart decompensation. The landmark European TRUFFLE trial demonstrated that timing delivery based on ductus venosus abnormalities or computerized CTG short-term variation optimizes neurological intact survival. Once a reversed a-wave is confirmed in early-onset FGR after 26–28 weeks, immediate delivery is indicated after steroid administration.
10A routine ultrasound at 18 weeks of gestation in a monochorionic diamniotic (MCDA) twin pregnancy reveals a deepest vertical pocket (DVP) of amniotic fluid of 10 cm in Twin A's sac and 1.5 cm in Twin B's sac. What diagnosis is established according to Eurofetus/Quintero criteria?
A.Twin-to-Twin Transfusion Syndrome (TTTS) Stage I
B.Twin Anemia-Polycythemia Sequence (TAPS) Stage II
C.Selective Fetal Growth Restriction (sFGR) Type III
D.Normal physiological discordance in monochorionic amniotic fluid dynamics
Explanation: Twin-to-Twin Transfusion Syndrome (TTTS) is diagnosed in monochorionic pregnancies by the presence of oligohydramnios (DVP <= 2.0 cm) in the donor twin and polyhydramnios (DVP >= 8.0 cm before 20 weeks, or >= 10.0 cm thereafter) in the recipient twin, caused by unbalanced arteriovenous anastomoses on the shared placental surface. Under the Quintero staging system, Stage I is defined by this polyhydramnios/oligohydramnios sequence with the donor's urinary bladder still visible on ultrasound and normal Doppler findings.

About the Czech Gynaecology and Obstetrics Board Exam Exam

The Atestační zkouška v oboru Gynekologie a porodnictví is the statutory Czech postgraduate specialty examination under Zákon č. 95/2004 Sb. and Vyhláška č. 282/2019 Sb. The current program requires practical surgical, endoscopic, and ultrasound assessment followed by three drawn oral expert questions; a December 2021 amendment removed the former written work, preliminary test, and defense requirements. This independent English-language MCQ bank adapts the published curriculum for study; it is not an official translation or format simulation and does not substitute for oral or procedural preparation.

Assessment

The statutory examination comprises two mandatory parts: a practical clinical part conducted in an accredited hospital department evaluating patient clinical assessment, diagnostic reasoning, obstetrical/surgical operative technique, and logbook verification; and an oral theoretical board examination before an examination committee of at least three members appointed under Vyhláška č. 282/2019 Sb. Candidates draw questions covering obstetrics and perinatology, general and operative gynaecology, and gynaecological oncology and endocrinology.

Time Limit

No fixed total duration is published; oral preparation is at least 30 minutes, with practical assessment as required by the specialty program.

Passing Score

Grade of 'prospěl/a' awarded by consensus or majority vote of the at least 3-member committee under Vyhláška č. 282/2019 Sb.

Exam Fee

CZK 500 (CZK 250 practical, CZK 250 theoretical) under Nařízení vlády č. 324/2018 Sb.; 1st retake CZK 3,500; 2nd retake CZK 5,000 (Ministerstvo zdravotnictví České republiky (MZ ČR) / Lékařské fakulty / IPVZ)

Czech Gynaecology and Obstetrics Board Exam Exam Content Outline

Not published

Obstetrics & Maternal-Fetal Medicine

Antenatal screening, preeclampsia and hypertensive disorders, gestational diabetes mellitus, fetal growth restriction, alloimmunisation, multiple gestations, preterm labor evaluation, and maternal co-morbidities.

Not published

Labor, Delivery & Obstetric Emergencies

Active management of labor, electronic fetal heart rate monitoring (FIGO CTG criteria), postpartum haemorrhage (PPH protocols), operative vaginal delivery, caesarean sections, shoulder dystocia, and maternal collapse.

Not published

General & Operative Gynaecology

Benign uterine and adnexal pathology, pelvic pain, endometriosis, pelvic organ prolapse, urinary incontinence, ectopic pregnancy, pelvic infections, and complications of laparoscopy and laparotomy.

Not published

Gynaecological Oncology

Screening and colposcopy, cervical cancer staging and surgery, endometrial hyperplasia and carcinoma, ovarian cancer primary debulking and systemic therapy, and vulvar cancer management.

Not published

Reproductive Medicine & Endocrinology

Anovulatory disorders, PCOS, hyperprolactinaemia, infertility investigations, controlled ovarian stimulation, ART techniques, hormonal contraception, menopausal hormone therapy, and paediatric gynaecology.

How to Pass the Czech Gynaecology and Obstetrics Board Exam Exam

What You Need to Know

  • Passing score: Grade of 'prospěl/a' awarded by consensus or majority vote of the at least 3-member committee under Vyhláška č. 282/2019 Sb.
  • Assessment: The statutory examination comprises two mandatory parts: a practical clinical part conducted in an accredited hospital department evaluating patient clinical assessment, diagnostic reasoning, obstetrical/surgical operative technique, and logbook verification; and an oral theoretical board examination before an examination committee of at least three members appointed under Vyhláška č. 282/2019 Sb. Candidates draw questions covering obstetrics and perinatology, general and operative gynaecology, and gynaecological oncology and endocrinology.
  • Time limit: No fixed total duration is published; oral preparation is at least 30 minutes, with practical assessment as required by the specialty program.
  • Exam fee: CZK 500 (CZK 250 practical, CZK 250 theoretical) under Nařízení vlády č. 324/2018 Sb.; 1st retake CZK 3,500; 2nd retake CZK 5,000

Keys to Passing

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Czech Gynaecology and Obstetrics Board Exam Study Tips from Top Performers

1Master the ČGPS ČLS JEP and FIGO 2015 consensus guidelines on intrapartum fetal monitoring (cardiotocography) and scalp blood sampling indications.
2Review the stepped clinical protocol for postpartum haemorrhage (PPH), from uterotonics and intrauterine balloon tamponade to compression sutures, uterine artery embolisation, and peripartum hysterectomy.
3Understand the modern molecular and FIGO 2023 staging classifications for endometrial and cervical carcinomas, including POLE, MMR, and p53 status.
4Thoroughly review reproductive endocrinology algorithms for anovulation (Rotterdam PCOS criteria, hyperprolactinaemia workup) and safety protocols for ovarian hyperstimulation syndrome (OHSS).

Frequently Asked Questions

What is the official format of the Czech Gynaecology and Obstetrics Specialty Board Exam?

Under Zákon č. 95/2004 Sb. and Vyhláška č. 282/2019 Sb., the official atestace is not a computer-based multiple-choice test. It consists of a practical clinical examination in an accredited healthcare facility followed by a theoretical oral examination in front of an expert committee of at least three members. This practice bank is an English-language study adaptation based on official Věstník MZ ČR educational programs.

Who administers the medical specialty examinations in the Czech Republic?

The examination is administered under the statutory authority of the Ministry of Health of the Czech Republic (Ministerstvo zdravotnictví ČR — MZ ČR), which delegates the organization to accredited medical faculties (lékařské fakulty) and the Institute for Postgraduate Medical Education (IPVZ).

What are the legal fees for sitting the Czech atestace?

Under Government Regulation No. 324/2018 Sb. (Nařízení vlády č. 324/2018 Sb.), the first examination sitting costs CZK 500 (CZK 250 for the practical part and CZK 250 for the theoretical part). If a retake is necessary, the fee is CZK 3,500 for the first retake and CZK 5,000 for the second retake.

How long is the residency training before taking the atestace in Gynaecology and Obstetrics?

The minimum postgraduate specialty training duration is 5 years (60 months) of full-time training in accredited clinical departments, consisting of a foundational gynaecological/surgical trunk followed by specialized training in obstetrics, gynaecological surgery, oncogynaecology, perinatology, and allied rotations.

How many retakes are permitted under Czech healthcare legislation?

Under Zákon č. 95/2004 Sb. and Vyhláška č. 282/2019 Sb., a candidate may retake the examination at most twice (maximum of three attempts in total). An unsuccessful candidate can sit a retake no earlier than six months after the failed attempt.

What clinical guidelines form the standard of care for the examination?

Theoretical and practical questions are assessed according to the clinical recommended guidelines of the Czech Gynaecological and Obstetrical Society of the Czech Medical Association of J. E. Purkyně (ČGPS ČLS JEP), alongside European standards from EBCOG, ESHRE, ESGO, and FIGO.